October 04, 2011
A New York federal judge on Tuesday reopened Pfizer Inc.'s patent infringement suit against Apotex Inc. over the company's plan to sell a generic version of the migraine drug Relpax, after a proposed settlement fell through.
July 27, 2011
Pfizer Inc. notified a New York federal judge Tuesday that it was close to settling a patent infringement suit over rival Apotex Inc.'s plan to sell a generic version of the migraine drug Relpax.